About Developmental Therapeutics Research Program
The Developmental Therapeutics program at the UAMS Winthrop P. Rockefeller Cancer Institute focuses on developing hypotheses and evidence-based translational strategies for improved cancer treatment.Learn More
The Developmental Therapeutics Program meets monthly on the 3rd Thursday at 4:00pm. Please contact Laura Rakes for more information email@example.com
The NCI Cancer Centers Program was created as part of the National Cancer Act of 1971 and is one of the anchors of the nation’s cancer research effort. Through this program, NCI recognizes centers around the country that meet rigorous standards for transdisciplinary, state-of-the-art research focused on developing new and better approaches to preventing, diagnosing, and treating cancer.
Emphasis is placed on technology associated with the discovery and development of small molecule drug agents and biological therapies followed by validation using preclinical and clinical models.
Our objective is to optimize therapies through the generation, integration and translation of scientific information between the bench and the bedside, the patient and the population.
Program members have a wide range of expertise and practical experience in applying for Investigational New Drug (IND) applications and conducting IND studies and clinical trials.
Entrepreneurship and positive impact on the local economy.
From Bed Side to Bench and Bench to Bed side
Aim 1. Discovery
Therapeutic Targets and Biomarkers
- New Oncogene Mutation
- Radiomics & Radiogenomics
Aim 2. Preclinical Studies
Model Systems/Drug Development & Delivery
- PDX animal models
- Drug Development
- Biomarker validation
Aim 3. Clinical Trials
Applying IND and Phase 1 and 2 Studies
- Establish phase I clinical trial unit
- Biomarker driven clinical trials
- Novel combination clinical trials